Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Journal of Clinical Investigation

• Publication date

  1991-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI115102PMID 1999503PMCID PMC329886
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta.

  1990cited by this paper
• Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor.

  1990cited by this paper
• Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor.

  1990cited by this paper
• In vitro study of mediators of inflammation in multiple sclerosis

  1989cited by this paper
• Tumor necrosis factor alpha (TNF alpha) and neurological diseases. Failure in detecting TNF alpha in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumours.

  1989cited by this paper
• Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus.

  1989cited by this paper
• Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis

  1989cited by this paper
• Increase in permeability of human endothelial cell monolayer by recombinant human lymphotoxin.

  1989cited by this paper
• Endothelial cell activation induced by tumor necrosis factor and lymphotoxin.

  1989cited by this paper
• Tumor necrosis factor identified in multiple sclerosis brain

  1989cited by this paper
• Tumor necrosis factor alpha (TNFα) and neurological diseases Failure in detecting TNFα in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumours

  1989cited by this paper
• Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

  1988cited by this paper
• Tumor necrosis factor.

  1988cited by this paper
• The role of lymphotoxin in inflammation.

  1988cited by this paper
• Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations?

  1988cited by this paper
• Tumor necrosis factor-alpha and tumor necrosis factor-beta (lymphotoxin) stimulate the production of granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and IL-1 in vivo.

  1988cited by this paper
• Destruction of Rat Islet Cell Monolayers by Cytokines: Synergistic Interactions of Interferon-γ, Tumor Necrosis Factor, Lymphotoxin, and Interleukin 1

  1988cited by this paper
• Antigen presentation and tumor cytotoxicity by interferon‐γ‐treated microglial cells

  1987cited by this paper
• Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells.

  1987cited by this paper
• Growth-promoting effect of recombinant interleukin 1 and tumor necrosis factor for a human astrocytoma cell line.

  1987cited by this paper
• Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes

  1987cited by this paper
• Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells.

  1987cited by this paper
• Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes.

  1987cited by this paper
• Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species.

  1987cited by this paper
• Human disease: Mechanisms in multiple sclerosis

  1985cited by this paper
• Mechanisms in multiple sclerosis.

  1985cited by this paper
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

  1983cited by this paper
• An endotoxin-induced serum factor that causes necrosis of tumors.

  1975cited by this paper

• Cytokine Dynamics in Multiple Sclerosis: Modulating Adaptive Immunity in Neuroinflammation

  2026cites this paper
• Extracellular vesicles derived from cerebrospinal fluid of patients with multiple sclerosis contain inflammatory cytokines: a possible biomarker potential

  2026cites this paper
• Assessing Peripheral Blood Biomarkers and Predictive Patterns in Multiple Sclerosis Using Cytokines and Immune Gene Expression Profiles in Ocrelizumab-Treated Patients: Tracking Tumor Necrosis Factor

  2025cites this paper
• Pro-Inflammatory Protein PSCA Is Upregulated in Neurological Diseases and Targets β2-Subunit-Containing nAChRs

  2025cites this paper
• Astrocyte Activation and Drug Target in Pathophysiology of Multiple Sclerosis.

  2024cites this paper
• Inflammation-induced TRPV4 channels exacerbate blood–brain barrier dysfunction in multiple sclerosis

  2024cites this paper
• TNFR2 signaling in oligodendrocyte precursor cells suppresses their immune-inflammatory function and detrimental microglia activation in CNS demyelinating disease.

  2024cites this paper
• The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse?

  2024cites this paper
• Lymphotoxins from distinct types of lymphoid cells differentially contribute to neuroinflammation

  2024cites this paper
• Astrogliosis in multiple sclerosis and neuro-inflammation: what role for the notch pathway?

  2023cites this paper
• Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis

  2023cites this paper
• Inhibition of pro-inflammatory signaling in human primary macrophages by enhancing arginase-2 via target site blockers

  2023cites this paper
• THE CONCENTRATION OF INTERLEUKIN 6 AND TUMOR NECROSIS FACTOR ALPHA IN SALIVA AND BLOOD OF PATIENTS WITH INACTIVE MULTIPLE SCLEROSIS AND COEXISTING HASHIMOTO’S THYROIDITIS

  2023cites this paper
• An optimized method for obtaining clinical‐grade specific cell subpopulations from human umbilical cord‐derived mesenchymal stem cells

  2022cites this paper
• Hesperetin, a Citrus Flavonoid, Ameliorates Inflammatory Cytokine-Mediated Inhibition of Oligodendroglial Cell Morphological Differentiation

  2022cites this paper
• CLMP Promotes Leukocyte Migration Across Brain Barriers in Multiple Sclerosis

  2022cites this paper
• Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications

  2022cites this paper
• Potential neurotoxic activity of diverse molecules released by microglia.

  2021cites this paper
• Type I interferon therapies of multiple sclerosis and hepatitis C virus infection

  2021cites this paper
• TNFR2 Signaling Regulates the Immunomodulatory Function of Oligodendrocyte Precursor Cells

  2021cites this paper
• Advances for the Development of In Vitro Immunosensors for Multiple Sclerosis Diagnosis

  2021cites this paper
• The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation

  2021cites this paper
• Regional diversity in oligodendrocyte progenitor cells

  2021cites this paper
• The effects of PDE inhibitors on multiple sclerosis: a review of in vitro and in vivo models.

  2021cites this paper
• Dereplication Based Strategy for Rapid Identification and Isolation of a Novel Anti-inflammatory Flavonoid by LCMS/MS from Colebrookea oppositifolia

  2021cites this paper
• Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration

  2021cites this paper
• TNFα in MS and Its Animal Models: Implications for Chronic Pain in the Disease

  2021cites this paper
• The Role of Astrocytes in the Neurorepair Process

  2021cites this paper
• N-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge.

  2021cites this paper
• Immune-mediated genesis of multiple sclerosis

  2020cites this paper
• Organotypic Brain Slice Culture Microglia Exhibit Molecular Similarity to Acutely-Isolated Adult Microglia and Provide a Platform to Study Neuroinflammation

  2020cites this paper
• Astrocytes and Microglia as Major Players of Myelin Production in Normal and Pathological Conditions

  2020cites this paper
• Multiple Sclerosis

  2020cites this paper
• Macroglial diversity and its effect on myelination

  2020cites this paper
• Plasmapheresis for Multiple Sclerosis in the Twenty-First Century: Take It or Leave It?

  2020cites this paper
• PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disorders

  2020cites this paper
• The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach

  2020cites this paper
• Altered astrocytic function in experimental neuroinflammation and multiple sclerosis

  2020cites this paper
• Tissue-specific features of microglial innate immune responses.

  2020cites this paper
• Re-Examining the Role of TNF in MS Pathogenesis and Therapy

  2020cites this paper
• Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis

  2020cites this paper
• Astrocyte phenotypes: Emphasis on potential markers in neuroinflammation.

  2020cites this paper
• Encephalopathy

  2019cites this paper
• Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis

  2019cites this paper
• CSF biomarkers of inflammation in trigeminal neuralgia patients operated with microvascular decompression.

  2019cites this paper
• The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis

  2019cites this paper
• Oligodendrocytes modulate the immune-inflammatory response in EAE via TNFR2 signaling.

  2019cites this paper
• Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation

  2018cites this paper
• On the role of macrophages, microglia and the extracellular matrix in remyelination

  2018cites this paper
• Facile synthesis of some pyrazoline-based compounds with promising anti-inflammatory activity.

  2018cites this paper
• Grey matter OPCs are less mature and less sensitive to IFNγ than white matter OPCs: consequences for remyelination

  2018cites this paper
• Serum amyloid A primes microglia for ATP-dependent interleukin-1β release

  2018influential citation
• Distinct Gene Profiles of Bone Marrow-Derived Macrophages and Microglia During Neurotropic Coronavirus-Induced Demyelination

  2018cites this paper
• Identification of N-benzyltetrahydroisoquinolines as novel anti-neuroinflammatory agents.

  2018cites this paper
• Genome-wide DNA methylation changes in CD19+ B cells from relapsing-remitting multiple sclerosis patients

  2018cites this paper
• In-vitro assessment of cytotoxicity, antioxidant and anti-inflammatory activities of Ficus palmata

  2017cites this paper
• An insight into lymphotoxin and TNF-α role in neuroinflammatory neurodegenerative diseases

  2017cites this paper
• SELECTIVELY LABELLING AND TARGETING TH1 LYMPHOCYTE BY MEANS OF THE LAG-3 PROTEIN

  2017cites this paper
• Expression and Differential Responsiveness of Central Nervous System Glial Cell Populations to the Acute Phase Protein Serum Amyloid A

  2017cites this paper
• Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis

  2017cites this paper
• Therapeutic strategies for neurodegenerative disorders

  2017cites this paper
• B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro.

  2017cites this paper
• Opposing Functions of Microglial and Macrophagic TNFR2 in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.

  2017cites this paper
• Four new carbazole alkaloids from Murraya koenigii that display anti-inflammatory and anti-microbial activities.

  2016cites this paper
• Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.

  2016cites this paper
• Neurological Complications of Anti-TNF Treatments and Other Neurological Aspects of Inflammatory Bowel Disease

  2016cites this paper
• Development of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditions

  2016cites this paper
• Genes differentially expressed by methylprednisolone in vivo in CD4 T lymphocytes from multiple sclerosis patients: potential biomarkers

  2016cites this paper
• The multifaceted role of astrocytes in regulating myelination

  2016cites this paper
• Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis

  2016influential citation
• Soluble Tumor Necrosis Factor Receptor 1 Released by Skin‐Derived Mesenchymal Stem Cells Is Critical for Inhibiting Th17 Cell Differentiation

  2016cites this paper
• TNF-α and IL-6 inhibitory effects of cyclic dipeptides isolated from marine bacteria Streptomyces sp

  2016cites this paper
• Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis

  2016cites this paper
• Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination

  2016cites this paper
• The Role of Cholesterol and Sphingolipids in Glomerular Disease

  2016cites this paper
• Inflammatory Mediators and the Blood-Brain Barrier

  2015cites this paper
• TNFR2 Deficiency Acts in Concert with Gut Microbiota To Precipitate Spontaneous Sex-Biased Central Nervous System Demyelinating Autoimmune Disease

  2015cites this paper
• Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: approved therapies and emerging candidates

  2015cites this paper
• TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects.

  2015cites this paper
• Direct and Indirect Effects of Immune and Central Nervous System–Resident Cells on Human Oligodendrocyte Progenitor Cell Differentiation

  2015cites this paper
• Emerging immunopharmacological targets in multiple sclerosis.

  2015cites this paper
• Tumor necrosis factor stimulates expression of CXCL12 in astrocytes.

  2015cites this paper
• Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.

  2015cites this paper
• A Comparison of Cytokine Profiles of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis Patients

  2015cites this paper
• Are PrP(C)s involved in some human myelin diseases? Relating experimental studies to human pathology.

  2015cites this paper
• Targeting of Tumor Necrosis Factor Alpha Receptors as a Therapeutic Strategy for Neurodegenerative Disorders

  2015cites this paper
• Bone Morphogenetic Proteins: Inhibitors of Myelination in Development and Disease.

  2015cites this paper
• The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.

  2015cites this paper
• Immunopathological Mechanisms and Oxidative Stress Damage in Multiple Sclerosis

  2014cites this paper
• From precursors to myelinating oligodendrocytes: contribution of intrinsic and extrinsic factors to white matter plasticity in the adult brain.

  2014cites this paper
• POLIMORFISMOS LINGO1 rs9652490 Y rs11856808 Y RIESGO PARA EL DESARROLLO DE ESCLEROSIS MÚLTIPLE

  2014cites this paper
• Synthesis of novel 1,2-benzothiazine 1,1-dioxide-3-ethanone oxime N-aryl acetamide ether derivatives as potent anti-inflammatory agents and inhibitors of monocyte-to-macrophage transformation.

  2014cites this paper
• Novel Potent Imidazo[1,2-a]pyridine-N-Glycinyl-Hydrazone Inhibitors of TNF-α Production: In Vitro and In Vivo Studies

  2014cites this paper
• Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis.

  2014cites this paper
• Development of Central Nervous System Autoimmunity Is Impaired in the Absence of Wiskott-Aldrich Syndrome Protein

  2014cites this paper
• Behavioural and neurobiological changes mediated by TNF-α signalling in the CNS

  2014cites this paper
• The role of lymphotoxin signaling in the development of autoimmune pancreatitis and associated secondary extra-pancreatic pathologies.

  2014cites this paper
• Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process

  2014cites this paper
• Chapter 52 – Multiple Sclerosis

  2014cites this paper
• Tumor necrosis factor beta NcoI polymorphism is associated with inflammatory and metabolic markers in multiple sclerosis patients.

  2014cites this paper